TOT BIOPHARM possesses advanced ADC conjugation and analysis technologies, and has established a rigorous quality management system and GMP-compliant commercial production base. With its validated R&D and industrialization platform for mAbs and ADCs, the company provides trusted one-stop CDMO services and serves as the best strategic partner in the field of ADC drug development.
One-site manufacturing, efficient resource utilization
Integrated ADC commercial production facility for antibodies, ADC DS and DP in one location. Faster timelines, optimal costs, lower risks.
High-quality development, comprehensive capabilities
Comprehensive ADC analysis technology platform and independent analysis capabilities of critical quality attributes, ensuring high-quality product development
Professional and experienced full-process service team
An integrated professional team provides services from R&D, process development, regulatory submission, clinical batch manufacturing, to commercial production, ensuring the smooth progression of the project
